A detailed history of Cetera Investment Advisers transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 59,001 shares of SENS stock, worth $46,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,001
Previous 59,101 0.17%
Holding current value
$46,020
Previous $23,000 13.04%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.32 - $0.49 $32 - $49
-100 Reduced 0.17%
59,001 $20,000
Q2 2024

Aug 22, 2024

BUY
$0.37 - $0.52 $7,548 - $10,608
20,400 Added 52.71%
59,101 $23,000
Q1 2024

May 24, 2024

BUY
$0.5 - $0.73 $19,350 - $28,251
38,701 New
38,701 $20,000
Q2 2017

Aug 14, 2017

BUY
N/A
27,800
27,800 $50,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $363M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.